FDA Warns API Maker Sal Pharma Over GMPs Following Import Alert

Drug Industry Daily
A A
The FDA issued a warning letter to an API manufacturing facility in Hyderabad, India, citing adulteration, misbranding and other issues.

To View This Article:

Login

Subscribe To Drug Industry Daily